HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia Zhou Selected Research

isospaglumic acid (NAAGA)

8/2008Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
1/2007Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
12/2005NAAG peptidase inhibitors and their potential for diagnosis and therapy.
7/2004Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia Zhou Research Topics

Disease

83Neoplasms (Cancer)
09/2022 - 12/2005
32Inflammation (Inflammations)
01/2022 - 01/2007
32Infections
01/2022 - 07/2011
18Breast Neoplasms (Breast Cancer)
05/2022 - 01/2011
15Fibrosis (Cirrhosis)
01/2022 - 07/2014
12Neoplasm Metastasis (Metastasis)
09/2022 - 02/2012
12Lung Neoplasms (Lung Cancer)
01/2022 - 01/2011
11Pain (Aches)
01/2021 - 07/2004
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 06/2006
6Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 01/2020
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2012
5Hypoxia (Hypoxemia)
11/2022 - 08/2012
5Mannose-Binding Protein Deficiency
01/2022 - 01/2019
5Virus Diseases (Viral Diseases)
01/2022 - 01/2020
5Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2011
5Pancreatitis
01/2021 - 06/2015
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 12/2016
5Diarrhea
12/2019 - 04/2015
5Vitiligo
06/2019 - 07/2015
5Schizophrenia (Dementia Praecox)
01/2019 - 05/2004
5Melanoma (Melanoma, Malignant)
01/2019 - 02/2012
5Traumatic Brain Injuries (Traumatic Brain Injury)
06/2013 - 05/2006
4Triple Negative Breast Neoplasms
09/2022 - 10/2016
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 09/2016
4Heart Failure
01/2022 - 05/2014
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 10/2015
4Glioblastoma (Glioblastoma Multiforme)
12/2021 - 07/2017
4Necrosis
12/2021 - 01/2016
4Hypersensitivity (Allergy)
12/2021 - 01/2018
4Zika Virus Infection
12/2021 - 01/2019
4Respiratory Syncytial Virus Infections
11/2021 - 11/2018
4Non-alcoholic Fatty Liver Disease
08/2021 - 03/2019
4COVID-19
06/2021 - 01/2020
4Neuralgia (Stump Neuralgia)
01/2021 - 07/2004
4Cicatrix (Scar)
01/2021 - 01/2014
4Neuroinflammatory Diseases
01/2021 - 08/2008
4Hypertrophic Cicatrix (Hypertrophic Scar)
01/2021 - 02/2016
4Stomach Neoplasms (Stomach Cancer)
10/2020 - 07/2014
4Ischemia
05/2020 - 03/2010
4Reperfusion Injury
05/2020 - 10/2015
4Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2014
4Nervous System Diseases (Neurological Disorders)
01/2020 - 05/2014
4Airway Remodeling
01/2020 - 01/2019
4Nausea
06/2018 - 04/2015
3Dengue (Dengue Fever)
02/2022 - 10/2016
3Chest Pain (Chest Pains)
01/2022 - 01/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2017
3Arthritis (Polyarthritis)
01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
05/2022 - 05/2009
44Pharmaceutical PreparationsIBA
04/2022 - 05/2009
18Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2016
18Biological ProductsIBA
01/2022 - 11/2010
12oridoninIBA
07/2021 - 06/2013
10CytokinesIBA
06/2022 - 01/2016
10Messenger RNA (mRNA)IBA
09/2021 - 07/2012
9Liposomes (Liposome)IBA
06/2022 - 05/2009
8MicroRNAs (MicroRNA)IBA
01/2022 - 12/2015
8erythromycin propionate-N-acetylcysteinateIBA
11/2021 - 01/2013
8EnzymesIBA
01/2019 - 01/2007
7Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
06/2013 - 05/2004
6Therapeutic UsesIBA
09/2022 - 01/2019
6CalciumIBA
06/2022 - 01/2018
6Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
06/2022 - 12/2017
6Peptides (Polypeptides)IBA
05/2022 - 01/2007
6CollagenIBA
01/2021 - 02/2016
6Analgesics (Analgesic Drugs)IBA
04/2020 - 07/2004
6LipidsIBA
12/2019 - 08/2014
5VaccinesIBA
05/2022 - 11/2018
5RNA (Ribonucleic Acid)IBA
04/2022 - 07/2019
5Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 02/2014
5Amino AcidsFDA Link
01/2022 - 11/2010
5Antiviral Agents (Antivirals)IBA
12/2021 - 01/2019
5LigandsIBA
07/2021 - 11/2004
5Glutamic Acid (Glutamate)FDA Link
01/2021 - 05/2006
5Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 04/2013
5NiclosamideFDA Link
11/2020 - 02/2013
5STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2020 - 01/2014
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2020
4Phosphotransferases (Kinase)IBA
12/2021 - 01/2019
4Alanine Transaminase (SGPT)IBA
12/2021 - 01/2016
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2021 - 01/2016
4AcidsIBA
01/2021 - 03/2010
4Adenosine Monophosphate (AMP)IBA
09/2020 - 03/2010
4Cytochromes c (Cytochrome c)IBA
09/2019 - 02/2012
4Melanins (Melanin)IBA
06/2019 - 09/2012
4DiterpenesIBA
02/2018 - 06/2013
4isospaglumic acid (NAAGA)IBA
08/2008 - 07/2004
3Peptide Hydrolases (Proteases)FDA Link
02/2022 - 12/2005
3Long Noncoding RNAIBA
01/2022 - 01/2020
3Histones (Histone)IBA
01/2022 - 08/2008
3EscitalopramFDA Link
01/2022 - 01/2021
3C-Reactive ProteinIBA
01/2022 - 01/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 03/2015
3BerberineIBA
01/2022 - 06/2013
3Freund's AdjuvantIBA
01/2022 - 12/2016

Therapy/Procedure

65Therapeutics
01/2022 - 12/2005
12Drug Therapy (Chemotherapy)
07/2021 - 05/2009
6Electroacupuncture
01/2021 - 10/2015
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 11/2014
3Subcutaneous Injections
01/2022 - 01/2021